189
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of the effect of bilateral subthalamic nucleus deep brain stimulation on fatigue in Parkinson’s Disease as measured by the non-motor symptoms scale

ORCID Icon, , , , , , , , , , , & ORCID Icon show all
Pages 712-715 | Received 13 Dec 2020, Accepted 23 Jul 2021, Published online: 06 Aug 2021

References:

  • Bruno AE, Sethares KA. Fatigue in Parkinson disease: an integrative review. J Neurosci Nurs 2015;47:146–53.
  • Friedman JH, Brown RG, Comella C, et al. Fatigue in Parkinson’s disease: a review. Mov Disord 2007;22:297–308.
  • Lazcano-Ocampo C, Wan YM, van Wamelen DJ, et al. Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice. Expert Rev Neurother 2020;20:477–95.
  • Dafsari HS, Weiß L, Silverdale M, et al. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease. Brain Stimul 2018;11:867–74.
  • Havlikova E, Rosenberger J, Nagyova I, et al. Impact of fatigue on quality of life in patients with Parkinson’s disease. Eur J Neurol 2008;15:475–80.
  • Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver’s burden in Parkinson’s disease. Parkinsonism Relat Disord 2015;21:629–34.
  • van Wamelen DJ, Sauerbier A, Leta V, et al. Cross-sectional analysis of the Parkinson’s disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life. Sci Rep 2021;11:9611.
  • Friedman JH, Chou KL. Sleep and fatigue in Parkinson’s disease. Parkinsonism Relat Disord 2004;10:S27–S35.
  • Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003;60:1119–24.
  • Friedman JH, Beck JC, Chou KL, et al. Fatigue in Parkinson’s disease: report from a mutidisciplinary symposium. NPJ Parkinsons Dis 2016;2:15025.
  • Kluger BM, Herlofson K, Chou KL, et al. Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord 2016;31:625–31.
  • Nassif DV, Pereira JS. Fatigue in Parkinson’s disease: concepts and clinical approach. Psychogeriatrics 2018;18:143–50.
  • Martino D, Tamburini T, Zis P, et al. An objective measure combining physical and cognitive fatigability: correlation with subjective fatigue in Parkinson’s disease. Parkinsonism Relat Disord 2016;32:80–6.
  • Chou KL, Kotagal V, Bohnen NI. Neuroimaging and clinical predictors of fatigue in Parkinson disease. Parkinsonism Relat Disord 2016;23:45–9.
  • Pavese N, Metta V, Bose SK, et al. Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010;133:3434–43.
  • Lindqvist D, Hall S, Surova Y, et al. Cerebrospinal fluid inflammatory markers in Parkinson’s disease–associations with depression, fatigue, and cognitive impairment. Brain Behav Immun 2013;33:183–9.
  • Chaudhuri A, Behan PO. Fatigue and basal ganglia. J Neurol Sci 2000;179:34–42.
  • Dulski J, Schinwelski M, Konkel A, et al. The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2019;64:138–44.
  • Kluger BM. Fatigue in Parkinson’s Disease. Int Rev Neurobiol 2017;133:743–68.
  • Seppi K, Ray Chaudhuri K, Coelho M, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review. Mov Disord 2019;34:180–98.
  • Dafsari HS, Reddy P, Herchenbach C, et al. Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson’s Disease. Brain Stimul 2016;9:78–85.
  • Kluger BM, Parra V, Jacobson C, et al. The prevalence of fatigue following deep brain stimulation surgery in Parkinson’s disease and association with quality of life. Parkinsons Dis 2012;2012:1–5. 2012, 769506.
  • Dafsari HS, Martinez-Martin P, Rizos A, et al. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson’s disease. Mov Disord 2019;34:353–65.
  • Martinez-Martin P, Reddy P, Katzenschlager R, et al. EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease. Mov Disord 2015;30:510–6.
  • Chou KL, Persad CC, Patil PG. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease. Parkinsonism Relat Disord 2012;18:510–3.
  • Dafsari HS, Silverdale M, Strack M, et al. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson’s disease. Mov Disord 2018;33:421–30.
  • Gulberti A, Hamel W, Buhmann C, et al. Subthalamic deep brain stimulation improves auditory sensory gating deficit in Parkinson’s disease. Clin Neurophysiol 2015;126:565–74.
  • Wichmann T, DeLong MR. Deep Brain Stimulation for Movement Disorders of Basal Ganglia origin: restoring function or functionality? Neurotherapeutics 2016;13:264–83.
  • Funkiewiez A, Ardouin C, Krack P, et al. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease. Mov Disord 2003;18:524–30.
  • Dhawan V, Healy DG, Pal S, et al. Sleep-related problems of Parkinson’s disease. Age Ageing 2006;35:220–8.
  • Valko PO, Waldvogel D, Weller M, et al. Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 2010;17:1428–36.
  • Titova N, Chaudhuri KR. Non-motor Parkinson disease: new concepts and personalised management. Medical Journal of Australia 2018;208:404–9.
  • Dafsari HS, Ray-Chaudhuri K, Mahlstedt P, et al. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson’s disease. Eur J Neurol 2019;26:222–e217.
  • Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 2007;22:1901–11.
  • Chaudhuri KR, Odin P, Antonini A, et al. Parkinson’s disease: the non-motor issues. Parkinsonism Relat Disord 2011;17:717–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.